Answers are grounded in this paper and cite their sources.
Timolol maleate is an effective agent of reducing intraocular pressure in patients with chronic open-angle glaucoma. To date, there are no adverse side effects demonstrable with use of this medication. Its mechanism of action is not clearly delineated but preliminary data suggest an effect on outflow facility.
No takes yet. Share an insight, caveat, or question.
Sa et al. (1978) studied this question.
Synapse has enriched 2 related papers. Consider them for comparative context: